390 related articles for article (PubMed ID: 37464092)
1. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.
Kim YS; Hurley EH; Park Y; Ko S
Exp Mol Med; 2023 Jul; 55(7):1380-1387. PubMed ID: 37464092
[TBL] [Abstract][Full Text] [Related]
2. The microbiota and the gut-liver axis in primary sclerosing cholangitis.
Hov JR; Karlsen TH
Nat Rev Gastroenterol Hepatol; 2023 Mar; 20(3):135-154. PubMed ID: 36352157
[TBL] [Abstract][Full Text] [Related]
3. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.
Henriksen EK; Jørgensen KK; Kaveh F; Holm K; Hamm D; Olweus J; Melum E; Chung BK; Eide TJ; Lundin KE; Boberg KM; Karlsen TH; Hirschfield GM; Liaskou E
J Hepatol; 2017 Jan; 66(1):116-122. PubMed ID: 27647428
[TBL] [Abstract][Full Text] [Related]
4. The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.
Torres J; Palmela C; Brito H; Bao X; Ruiqi H; Moura-Santos P; Pereira da Silva J; Oliveira A; Vieira C; Perez K; Itzkowitz SH; Colombel JF; Humbert L; Rainteau D; Cravo M; Rodrigues CM; Hu J
United European Gastroenterol J; 2018 Feb; 6(1):112-122. PubMed ID: 29435321
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
6. PSC associated inflammatory bowel disease: a distinct entity.
Beheshti-Maal A; Tamimi A; Iravani S; Memarnejadian A; Sorouri M; Aghdaei HA; Zali MR; Hossein Khannazer N; Vosough M
Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):129-139. PubMed ID: 35078376
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
[TBL] [Abstract][Full Text] [Related]
9. A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis.
Stumme F; Steffens N; Steglich B; Mathies F; Nawrocki M; Sabihi M; Soukou-Wargalla S; Göke E; Kempski J; Fründt T; Weidemann S; Schramm C; Gagliani N; Huber S; Bedke T
Front Immunol; 2024; 15():1307297. PubMed ID: 38510236
[TBL] [Abstract][Full Text] [Related]
10. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
[TBL] [Abstract][Full Text] [Related]
13. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
van Munster KN; Bergquist A; Ponsioen CY
J Hepatol; 2024 Jan; 80(1):155-168. PubMed ID: 37940453
[TBL] [Abstract][Full Text] [Related]
15. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis.
Wittek A; Steglich B; Casar C; Seiz O; Huber P; Ehlken H; Reher D; Wende S; Bedke T; Kempski J; Böttcher M; Bang C; Thingholm L; Krech T; Lohse AW; Sauter G; Rösch T; Franke A; Schramm C; Gagliani N; Pelczar P; Huber S
Inflamm Bowel Dis; 2024 Jun; 30(6):900-910. PubMed ID: 37540889
[TBL] [Abstract][Full Text] [Related]
16. Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis.
de Krijger M; Wildenberg ME; de Jonge WJ; Ponsioen CY
J Hepatol; 2019 Sep; 71(3):603-615. PubMed ID: 31108158
[TBL] [Abstract][Full Text] [Related]
17. The IBD and PSC Phenotypes of PSC-IBD.
Ricciuto A; Kamath BM; Griffiths AM
Curr Gastroenterol Rep; 2018 Mar; 20(4):16. PubMed ID: 29594739
[TBL] [Abstract][Full Text] [Related]
18. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation.
Hole MJ; Jørgensen KK; Holm K; Braadland PR; Meyer-Myklestad MH; Medhus AW; Reikvam DH; Götz A; Grzyb K; Boberg KM; Karlsen TH; Kummen M; Hov JR
Hepatology; 2023 Mar; 77(3):715-728. PubMed ID: 36056902
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
[TBL] [Abstract][Full Text] [Related]
20. The Gut-Liver Axis in Primary Sclerosing Cholangitis.
Eksteen B
Clin Liver Dis; 2016 Feb; 20(1):1-14. PubMed ID: 26593287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
